CRVS: Corvus Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 283.37
Enterprise Value ($M) 278.69
Book Value ($M) 12.41
Book Value / Share 0.19
Price / Book 22.84
NCAV ($M) -3.48
NCAV / Share -0.05
Price / NCAV -81.31

Profitability (mra)
Return on Invested Capital (ROIC) -4.45
Return on Assets (ROA) -1.25
Return on Equity (ROE) -1.47

Liquidity (mrq)
Quick Ratio 0.92
Current Ratio 0.92

Balance Sheet (mrq) ($M)
Current Assets 42.92
Assets 58.81
Liabilities 46.41
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
8 days ago 13G/A Samlyn Capital, Llc
9 days ago 13G/A Miller Richard A Md
05-09 13G Point72 Asset Management, L.P. 9.90
05-08 13D/A Orbimed Advisors Llc 11.10 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 93,302 948,277 9.84
2025-02-20 84,169 425,330 19.79
2025-02-19 82,824 451,887 18.33
2025-02-18 63,387 452,244 14.02

(click for more detail)

Similar Companies
CRMD – CorMedix Inc. CRON – Cronos Group Inc.
CRSP – CRISPR Therapeutics AG CURR – CURRENC Group Inc.
CVAC – CureVac N.V.


Financial data and stock pages provided by
Fintel.io